| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mibefradil | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
0.55 | investigational,withdrawn | inhibitor,blocker |
| mibefradil | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent l-type calcium channel subunit alpha-1f | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent t-type calcium channel subunit alpha-1g | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
1.31 | investigational,withdrawn | inhibitor,blocker |
| mibefradil | voltage-dependent t-type calcium channel subunit alpha-1h | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
1.34 | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent t-type calcium channel subunit alpha-1h | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
1.34 | investigational,withdrawn | inhibitor,blocker |
| mibefradil | voltage-gated calcium channel alpha cav3.2 | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
1.34 | phase 1 | unknown |
| mibefradil | voltage-gated calcium channel alpha cav3.2 | NA | Successful target | TTD , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
1.34 | phase 1 | blocker |
| mibefradil | voltage-dependent t-type calcium channel subunit alpha-1i | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
0.94 | investigational,withdrawn | inhibitor,blocker |
| mibefradil | voltage-dependent l-type calcium channel subunit alpha-1s | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent l-type calcium channel subunit beta-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent l-type calcium channel subunit beta-2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent l-type calcium channel subunit beta-3 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| mibefradil | voltage-dependent l-type calcium channel subunit beta-4 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris[MeSHID:D000787] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | investigational,withdrawn | inhibitor |
| click here to return to the previous page | ||||||||